Evidence map›Paper›PMID 30425782›Full record

ReviewOxidative medicine and cellular longevity2018

An Overview on the Anti-inflammatory Potential and Antioxidant Profile of Eugenol.

Joice Nascimento Barboza, Carlos da Silva Maia Bezerra Filho, Renan Oliveira Silva, Jand Venes R Medeiros, Damião Pergentino de Sousa

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
26.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 322 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Development of eugenol derivatives with 5-LOX inhibitory activity.Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Joice Nascimento BarbozaDepartment of Pharmaceutical Sciences, Universidade Federal da Paraíba, 58051-970 João Pessoa, Paraíba, Brazil.
Carlos da Silva Maia Bezerra FilhoDepartment of Pharmaceutical Sciences, Universidade Federal da Paraíba, 58051-970 João Pessoa, Paraíba, Brazil.
Renan Oliveira SilvaDepartment of Biomedicine, University Center INTA-UNINTA, 62050-130 Sobral, Ceará, Brazil.
Jand Venes R MedeirosLaboratory of Pharmacology of Inflammation and Gastrointestinal Disorders-LAFIDG, Federal University of Piauí, Parnaíba, Piauí, Brazil.ORCID 0000-0002-7234-3382
Damião Pergentino de SousaDepartment of Pharmaceutical Sciences, Universidade Federal da Paraíba, 58051-970 João Pessoa, Paraíba, Brazil.ORCID 0000-0002-4520-6577
Universidade Federal da Paraíba · BRInstituto Superior de Teologia Aplicada · BRUniversidade Federal do Piauí · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bioactive compounds found in foods and medicinal plants are attractive molecules for the development of new drugs with action against several diseases, such as those associated with inflammatory processes, which are commonly related to oxidative stress. Many of these compounds have an appreciable inhibitory effect on oxidative stress and inflammatory response, and may contribute in a preventive way to improve the quality of life through the use of a diet rich in these compounds. Eugenol is a natural compound that has several pharmacological activities, action on the redox status, and applications in the food and pharmaceutical industry. Considering the importance of this compound, the present review discusses its anti-inflammatory and antioxidant properties, demonstrating its mechanisms of action and therapeutic potential for the treatment of inflammatory diseases.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsBone RemodelingEugenolHumansInflammation MediatorsAnti-Inflammatory AgentsAntioxidantsEugenolInflammation Mediators

Identifiers

PMID30425782
PMCPMC6217746
OpenAlexW2897231194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.